The most influential people in biopharma today
Every year, FierceBiotech puts together a list of people that could play major roles in the evolution of the biopharma industry. This doesn’t necessarily mean that these people are successful. Failure and discord can change the industry as much as success and consensus.
Here is the list of the individuals shaping the future of biopharma in 2016:
- Mark Alles – Celgene
- Kyle Bass – Hayman Capital
- Jay Bradner – Novartis
- Olivier Brandicourt – Sanofi
- Hillary Clinton, et al.
- Andrew Conrad – Verily
- Deborah DiSanzo – IBM Watson Health
- Belén Garijo – Merck KGaA
- Kurt Graves – Intarcia
- Elizabeth Holmes – Theranos
- Scott Huennekens – Verb Surgical
- Andrew Left – Citron Research
- John Milligan – Gilead Sciences
- John Oyler – BeiGene
- Michael Pearson – Valeant
- Ian Read – Pfizer
- Martin Shkreli
- Jeffrey Shuren – FDA
- Simon Stevens – NHS England
- Andrew Thompson – Proteus
- Anne Wojcicki – 23andMe
- Janet Woodcock – FDA
